Report: FDA expected to OK 3rd vaccine dose for the immunocompromised
The Food and Drug Administration is preparing to revise its emergency use authorizations for the Pfizer and Moderna COVID-19 vaccines, allowing immunocompromised adults to get a third dose, two people familiar with the matter told NBC News.
The announcement is expected to come on Thursday, the people said. Both the Pfizer and Moderna vaccines involve two shots, but there is evidence that people who are immunocompromised may only develop low levels of antibodies after being vaccinated, if any at all. A recent study at Johns Hopkins University of organ transplant recipients, who take medicine to suppress their immune systems so their new organs aren't rejected, showed that a third vaccine dose increased their antibody levels.
In July, an advisory panel to the Centers for Disease Control and Prevention said extra doses must be approved for immunocompromised adults, who make up about 2.7 percent of the U.S. population.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
Outer Hebrides: a top travel destination
The Week Recommends Discover 'unspoiled beauty' of the Western Isles
By Tess Foley-Cox Published
-
The Biltmore Mayfair review: a quintessential slice of luxury London
The Week Recommends This swanky retreat in Grosvenor Square blends old-world glamour with modern comforts
By Caroline Dolby Published
-
Is ChatGPT's new search engine OpenAI's Google 'killer'?
Talking Point There's a new AI-backed search engine in town. But can it stand up to Google's decades-long hold on internet searches?
By Theara Coleman, The Week US Published
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published
-
McDonald's sued over E. coli linked to burger
Speed Read The outbreak has sickened at least 49 people in 10 states and left one dead
By Rafi Schwartz, The Week US Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
Israel, UN agree to Gaza pauses for polio vaccinations
Speed Read Gaza's first case of polio in 25 years was confirmed last week in a 10-month-old boy who is now partially paralyzed
By Rafi Schwartz, The Week US Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
WHO declares mpox a global health emergency
Speed Read An outbreak of the viral disease formerly known as monkeypox continues to spread in Africa
By Rafi Schwartz, The Week US Published
-
What is POTS and why is it more common now?
The explainer The condition affecting young women
By Devika Rao, The Week US Published